Astrocyte-Specific Genes Are Generally Demethylated in Neural Precursor Cells Prior to Astrocytic Differentiation by Hatada, Izuho et al.
Astrocyte-Specific Genes Are Generally Demethylated in
Neural Precursor Cells Prior to Astrocytic Differentiation
Izuho Hatada
1*, Masakazu Namihira
2, Sumiyo Morita
1, Mika Kimura
1, Takuro Horii
1, Kinichi Nakashima
2
1Laboratory of Genome Science, Biosignal Genome Resource Center, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan, 2Laboratory of
Molecular Neuroscience, Graduate School of Biological Sciences, Nara Institute of Science and Technology, Ikoma, Japan
Abstract
Epigenetic changes are thought to lead to alterations in the property of cells, such as differentiation potential. Neural
precursor cells (NPCs) differentiate only into neurons in the midgestational brain, yet they become able to generate
astrocytes in the late stage of development. This differentiation-potential switch could be explained by epigenetic changes,
since the promoters of astrocyte-specific marker genes, glial fibrillary acidic protein (Gfap) and S100b, have been shown to
become demethylated in late-stage NPCs prior to the onset of astrocyte differentiation; however, whether demethylation
occurs generally in other astrocyctic genes remains unknown. Here we analyzed DNA methylation changes in mouse NPCs
between the mid-(E11.5) and late (E14.5) stage of development by a genome-wide DNA methylation profiling method using
microarrays and found that many astrocytic genes are demethylated in late-stage NPCs, enabling the cell to become
competent to express these genes. Although these genes are already demethylated in late-stage NPCs, they are not
expressed until cells differentiate into astrocytes. Thus, late-stage NPCs have epigenetic potential which can be realized in
their expression after astrocyte differentiation.
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Introduction
DNA methylation usually occurs in mammalian cells at CpG
dinucleotides and approximately 60–90% of cytosines at these sites
aremethylated [1]. MostCpG-richDNAfragments,orCpGislands
in genes, have been thought to remain unmethylated even in cell
types that do not express the genes [2]. However, changes in DNA
methylation have been sporadically observed in CpG islands during
development and are thought to play important roles in the
regulation of cell type-specific gene expression [3,4]. DNA
methylation also participates in the regulation of differentiation
and embryonic development [5]. For example, inactivation of Oct3/
4 (Pou5f1) and Nanog genes by DNA methylation is important for
early development [6,7]. These genes are essential for maintaining
pluripotency of embryonic stem (ES) cells and early embryos
[8,9,10] and are also known as two of four genes which have been
shown to reprogram somatic cells to pluripotent stem (iPS) cells with
the essential characteristics of embryonic stem (ES) cells [11].
Epigenetic modification is also thought to play an important role
in altering the differentiation potential of neural precursor cells
(NPCs). NPCs differentiate only into neurons in the midgestational
brain, while they become able to generate astrocytes as gestation
proceeds [12]. The Janus kinase (JAK) signal transducer and
activator of the transcription(STAT) pathway, which is activated by
cytokines, including leukemia inhibitory factor (LIF), can effectively
induce astrocyte differentiation [13,14]. A particular cytosine
residue within a STAT3-binding site in the astrocyte-specific
marker glial fibrillary acidic protein (Gfap) gene promoter is highly
methylated in NPCs midgestation (E11.5) when astrogenesis does
not normally occur, while it becomes demethylated in late-stage
(E14.5) NPCs that are prone to differentiating into astrocytes [15].
Although these late-stage (E14.5) NPCs with demethylated
promoter do not express Gfap, the expression can be upregulated
upon differentiation by leukemia inhibitory factor (LIF), which
induces STAT3-activating cytokines [13,14].
Previously, we developed a genome-wide DNA methylation
analysis called Microarray-based Integrated Analysis of Methyla-
tion by Isoschizomers (MIAMI) using a microarray with genome-
wide probes and used for several applications [16,17]. With this
method, we detected DNA methylation using the methylation-
sensitive restriction enzyme Hpa II and its methylation-insensitive
isoschizomer Msp I.
Although the demethylation of Gfap is known in late-stage NPCs
prior to astrocyte differentiation [15], it is not known whether
other genes confer this astrocytic property to cells. To study the
role of DNA methylation in altering the differentiation potential of
NPCs, here we analyzed DNA methylation changes in mouse
NPCs between the mid-(E11.5) and late (E14.5) stages of
development by a genome-wide DNA methylation profiling
method using microarrays. We also compared the methylation
status with that of postnatal day 1 (P1) astrocytes.
Results and Discussion
Genome-wide profiling of DNA methylation
Methylation changes in the differentiation potential switch of
NPCs were analyzed by comparing mid-(E11.5) and late (E14.5)-
stage NPCs using the MIAMI method [16]. We also compared the
PLoS ONE | www.plosone.org 1 September 2008 | Volume 3 | Issue 9 | e3189methylation status with that of postnatal day 1 (P1) astrocytes.
Before analysis, the key genes involved in astrocyte differentiation,
such as Gfap and Stat3, were analyzed for DNA methylation in the
sample we used (Fig. 1). As described previously [15], the STAT3-
binding site of Gfap gene was demethylated in E14.5 NPCs prior to
astrocyte differentiation. On the other hand, the promoter of Stat3
gene was unmethylated throughout differentiation. The micro-
array used consisted of probes chosen from the Agilent promoter
array using an eArray system (http://earray.chem.agilent.com/
earray/). The probes are located on Hpa II fragments of less than 1
kilobasepair (kb) and cover 14,543 genes. Probes which showed
methylation changes at least in E14.5 NPCs or astrocytes
compared to E11.5 NPCs are presented in Fig. 2A and Table
S1 (Name of the probes and genes were indicated in Table S1). As
shown in Fig. 2B, E14.5 NPCs are hypomethylated in 85 probes
(80 genes) and hypermethylated in 15 probes (15 genes). On the
other hand, astrocytes are hypomethylated in 275 probes (256
genes) and hypermethylated in 170 probes (152 genes). The
reliability of the analysis was confirmed by bisulfite sequencing
analysis of eight genes (Fig. 3). The methylation ratio analyzed by
MIAMI (Fig. 3A) had good correlation with the methylation of
two Hpa II sites adjacent to the probes (Fig. 3B). Interestingly 80%
of the probes hypomethylated in E14.5 NPCs are also hypo-
methylated in astrocytes. (Fig. 2C). If we extend the hypomethyla-
tion change criteria to the threshold level (D10,0.5, usually we
use D10,0.2 for hypomethylation), 89% of the probes hypo-
methylated in E14.5 NPCs are also hypomethylated in astrocytes.
In other words, 48% of the hypomethylated probes in astrocytes
are also hypomethylated in E14.5 NPCs. These include a probe
for an astrocyte-specific marker gene, Gfap, which was previously
shown to be hypomethylated both in E14.5 NPCs and astrocytes
[15]. However, another hypomethylated astrocyte marker, S100b
[18], was not detected by the MIAMI method because the DNA
sequence with methylation change does not contain any Hpa II
sites, leading to underestimation of the total number of genes
actually demethylated in E14.5 NPCs. Nevertheless, including the
genes undetectable by MIAMI, many hypomethylated sequences
in astrocytes are already demethylated in E14.5 NPCs, which are
competent to differentiate into astrocytes. These include important
genes for astrocyte-specific function or phenotype in addition to an
astrocyte-specific marker gene, Gfap. For example, Aldolase C
encodes a member of the class I fructose-biphosphate aldolase
gene family specific to astrocytes (Aldoc, 19). The demethylated
region of Aldoc is located on exon 1. We further confirmed this
result by bisulfite sequencing and found that Aldoc was methylated
in E11.5 NPCs and demethylated in E14.5 NPCs and astrocytes
(Fig. 3B). Another example, Kcnj10 (Kir4.1), is widely expressed in
astrocytes throughout the brain [20]. The product of this gene is
absent in immature proliferating cells, and progressive expression
of the genes correlates with astrocyte differentiation, which is
characterized by the establishment of a negative membrane
potential and exit from the cell cycle. Kcnj10 (Kir4.1) encodes a
member of the inward rectifier-type potassium channel family,
characterized by having a greater tendency to allow potassium to
flow into, rather than out of, a cell, resulting in negative
membrane potential. The encoded protein is responsible for
potassium buffering action, which is a major function of astrocytes
and is also responsible for promoting differentiation and inhibiting
cell growth [20,21]. Mutations in this gene have been associated
with seizure susceptibility of common idiopathic generalized
epilepsy syndromes [22,23]. Sparcl1 is known as an astrocyte
marker colocalized with Gfap [24] and is also known as a candidate
gene for multiple sclerosis [25]. Cbs and BC055107 are also known
as astrocyte markers [26,27]. Thus, we found that demethylation
Figure 1. DNA methylation of Gfap and Stat3 gene. DNA methylation was analyzed by bisulfite sequencing. Closed circles indicate methylated
CpG sites and open circles indicate unmethylated CpG sites. STAT3 binding sites are indicated by arrows.
doi:10.1371/journal.pone.0003189.g001
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astrogenesis prior to astrocyte differentiation.
When comparing methylation status between E14.5 NPCs and
astrocytes, it is important to know what percentage of the E14.5
NPCs actually gives rise to astrocytes. After 4 day-culture in the
presence of LIF, 30–40% of E14.5 NPCs become GFAP-positive, yet
this does not necessary mean that Gfap promoter is methylated in all
GFP-negative cells. We have previously shown that STAT site within
the Gfap promoter was virtually unmethylated in E14.5 NPCs during
4-daycultureinthe proliferatingcondition.They,however,couldnot
give rise to 100% of GFAP-positive cells [15]. These findings suggest
the existence of other factors that inhibit astrocyte differentiation.
Thus, it is conceivable that demethylation is necessary but not
sufficient for NPCs to differentiate into GFAP-positive astrocytes.
Absolute levels of DNA methylation were analyzed by MIAMI
and were presented as average methylation ratio for hypomethy-
lated and hypermethylated genes compared to E11.5 NPCs
(Fig. 2D). On average, hypermethylated genes were nearly fully
methylated as expected. However, hypomethylated genes had
some methylation on average. In addition, some hypomethylated
genes, specially, Aldoc had highly mosaic pattern, suggesting a
possibility that equilibrium state may have been reached rather
than DNA demethylation (Fig. 3B).
A hallmark for Polycomb-mediated repression is methylation of
lysine 27 histone H3 (H3K27), which is set up by the Polycomb
repressive complex2 [28,29]. Many polycomb targets in embry-
onic stem cells (ESCs) have been shown to reside in a chromatin
state characterized not only by the dual presence of repressive
H3K27 methylation but also by active H3K4 methylation [30]. In
neural differentiation, the promoters marked by H3K27 methyl-
ation in ESCs are more likely to become de novo DNA methylated
[31]. Therefore, we analyzed the histone methylation status in
ESCs for our hypermethylated genes in astrocytes compared to
E11.5 NPCs using the published ESCs data [32]. We found that
promoter that were marked by H3K27 in ESCs were significantly
enriched in hypermethylated genes in astrocytes (P,1610
214).
Figure 2. Genome-wide profiling of DNA methylation. (A) Hypomethylated and hypermethylated genes in E14.5 NPCs and astrocytes
compared to E11.5 NPCs. Each row indicates each probe and each column indicates E14.5 NPCs or astrocytes. Probes with methylation changes are
indicated in color. D10 is a value indicating the difference between methylation-sensitive Hpa II cleavage and methylation-insensitive Msp I cleavage.
(B) Number of methylation changes in E14.5 NPCs and astrocytes compared to E11.5 NPCs. Numbers of methylation changes indicated in Fig. 1A were
counted and indicated by bars. (C) Venn diagram of the number of probes with methylation changes in E14.5 NPCs and astrocytes compared to E11.5
NPCs. (D) Absolute levels of DNA methylation analyzed by MIAMI presented as methylation ratio. Methylation ratios of hypermethylated and
hypomethylated probes are presented as average6standard deviation.
doi:10.1371/journal.pone.0003189.g002
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Expression changes during the differentiation potential switch of
NPCs were analyzed by comparing mid-(E11.5) and late (E14.5)-
stage NPCs, and astrocytes by expression microarray analysis
(Fig. 4, Table S2). We found that 49% of the probes upregulated
in E14.5 NPCs compared to E11.5 NPCs were also upregulated in
astroctyes (Fig. 3B). This is smaller than the ratio of hypomethyla-
tion where 80% of the probes hypomethylated in E14.5 NPCs
were also hypothylated in astrocytes (Fig. 2C). This implies that
astrocyte-specific genes, including Gfap, Aldoc, and Kcnj10 (Kir4.1),
are demethylated at E14.5 NPCs, while they are not expressed
until cells differentiate into astrocytes. To examine this hypothesis,
we analyzed the expression of genes hypomethylated both in
E14.5 NPCs and astrocytes. Among these genes, those that showed
upregulation in E14.5 NPCs or astrocytes compared to E11.5
NPCs are shown in Fig. 5. Of these, 64% of the genes, including
astrocyte-specific marker Gfap, showed more than twice the
expression level in astrocytes compared to E14.5 NPCs. Thus,
genes already demethylated, such as Gfap, Aldoc, and Kcnj10
(Kir4.1), were competent but not highly expressed in E14.5 NPCs,
Figure 3. Confirmation of genome-wide methylation profiling by MIAMI. (A) Methylation ratios of seven hypomethylated and one
hypermethylated gene compared to E11.5 NPCs. Methylation ratios are calculated by MIAMI data. (B) Confirmation of seven hypomethylated genes
and one hypermethylated gene by bisulfite sequencing analysis. Closed circles indicate methylated CpG sites and open circles indicate unmethylated
CpG sites. Positions of Hpa II sites are indicated as arrows.
doi:10.1371/journal.pone.0003189.g003
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astrocytes (Fig. 6). Astrocyte-specific genes probably require the
expression and/or activation of astrocyte-inducing transcription
factors, such as STAT3, to be effectively expressed (Fig. 6).
To analyze the relation between the DNA methylation and the
expression of genes, we plotted the methylation ratio calculated by
MIAMI and the expression level calculated by expression
microarray analysis for all genes examined (Fig. 7A). As expected,
the methylation ratio is inversely correlated to the expression level.
Next we analyzed the average expression levels of hypermethy-
lated and hypomethylated genes in astrocytes compared to E11.5
NPCs (Fig. 7B). Although there are some exceptions, we found the
average expression levels of hypermethylated genes were low and
those of hypomethylated genes were high in astrocytes. One of the
reasons which could explain the existence of exceptions is the wide
distribution of the probes (between 28000 to +2000 bases from
the transcription start sites). Interestingly, the expression levels of
hypomethylated genes were low in E14.5 NPCs compared to ones
in astrocytes. This again indicates activation of expression appears
after differentiation into astrocytes.
STAT and SMAD binding sites in demethylated and
upregulated genes
A CpG sequence in a conserved STAT-binding site in the Gfap
gene promoter is methylated in NPCs midgestation when
astrogliogenesis does not normally commence; however, it
becomes demethylated in late gestational NPCs that have gained
the potential to differentiate into astrocytes [15]. Thus, the Gfap
gene with the hypomethylated promoter can be expressed upon
astrocyte differentiation induced by LIF, which activates the JAK/
STAT signaling pathway [13]. Therefore, we searched for
conserved STAT-binding sites in the genes hypomethylated both
in E14.5 NPCs and astrocytes compared to E11.5 NPCs. To avoid
omitting threshold level genes, the threshold used in E14.5 NPCs
Figure 4. Expression analysis by microarray. (A) Number of
upregulated genes in E14.5 NPCs and astrocytes compared to E11.5
NPCs. (B) Venn diagram of the number of upregulated genes in E14.5
NPCs and astrocytes compared to E11.5 NPCs.
doi:10.1371/journal.pone.0003189.g004
Figure 5. Expression of the genes hypomethylated both in E14.5 NPCs and astrocytes compared to E11.5 NPCs. Among
hypomethylated genes, genes which showed upregulation in E14.5 NPCs or astrocytes compared to E11.5 NPCs are shown. Expression is calculated
from data obtained by expression microarray analysis and presented as fold change compared to E11.5 NPCs. Gfap is indicated by an arrow.
doi:10.1371/journal.pone.0003189.g005
Figure 6. Model proposed for astrocyte-specific expression of
the genes demethylated in E14.5 NPCs. Several astrocyte-specific
genes are already demethylated in E14.5 NPCs; however, they are
induced after diffentiation to astrocytes. This could be explained by
astrocyte-specific transcription factors.
doi:10.1371/journal.pone.0003189.g006
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upregulation in E14.5 NPCs or astrocytes compared to E11.5
NPCs were used for analysis (Fig. 8). Sequences including 500-
(basepair) bp upstream and 500-bp downstream of the probes were
searched for STAT3 binding sites with the CpG sequence (TTN4-
6AA, CG in any N position). Such methylation-sensitive STAT
binding sites were found among these 18 genes; however, none
were conserved between mice and humans except for Gfap, which
shows hypomethylation both in E14.5 NPCs and astrocytes (Fig. 1).
Although we cannot rule out the possibility that some demethyl-
ated STAT binding sites were not detected by the MIAMI method
because of its target limitation, these results suggest that not all
Figure 7. DNA methylation and expression. (A) All probes are grouped by their average methylation ratios and their expression levels are
indicated as average6standard error of mean. Expression levels are described as normalized values in log scale. (B) Expression levels of
hypermethylated (red) and hypomethylated (blue) genes in astrocytes. Expression levels are indicated as average6standard error of mean.
doi:10.1371/journal.pone.0003189.g007
Figure 8. Screening of conserved STAT and SMAD binding sites in demethylated and upregulated genes. Schematic representation of
screening of conserved STAT and SMAD binding sites in hypomethylated genes both in E14.5 NPCs and astrocytes. Numbers of genes are indicated in
parentheses.
doi:10.1371/journal.pone.0003189.g008
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STAT binding site methylation.
Bone morphogenetic proteins (BMPs) also use STATs to
activate the expression of astrocyte marker genes via the
association between STATs and the transactivating complex
composed of the MBP-activated signaling factors Smad1 and
P300/CBP [33,34]. Therefore, we also searched for conserved
SMADs-binding sites in the genes hypomethylated both in
E14.5NPCs and astrocytes compared to E11.5 NPCs. We found
methylation sensitive SMAD-binding sites in 6 genes; however,
only Aldoc was conserved between mouse and human (Fig. 8)
Bisulfite sequencing analysis of this SMAD sites reveals demeth-
ylation in E14.5 NPCs and astrocytes (Fig. 3B).
We could not find methylation-sensitive binding sites for
transcription factor except for Gfap and Aldoc. Effective activation
of demethylated genes in E14.5 NPCs probably requires
cooperation with other transcription factors, which are activated
in astrocyte differentiation.
Overrepresented genes with methylation changes
Overrepresented and underrepresented categories of genes were
searched in hypomethylated and hypermethylated genes. These
genes were first classified into lists using PANTHER classification
categories (http://www.pantherdb.org/tools/compareToRefList-
Form.jsp). Each list was then compared to the reference list using
the binomial test [35] for each molecular function, biological
process, or pathway term in PANTHER. Unexpectedly, there was
no significant overrepresentation and underrepresentation in
hypomethylated genes in E14.5 NPCs and in astrocytes
(P=0.01). On the other hand, biological process categories such
as ‘‘mRNA transcription regulation’’, ‘‘developmental processes’’,
‘‘mRNA transcription’’, ‘‘neurogenesis’’, ‘‘ectoderm develop-
ment’’, ‘‘nucleoside, nucleotide and nucleic acids metabolism’’
were overrepresented among hypermethylated genes in astrocytes
(P=0.01, Table 1). A molecular function category, ‘‘transcription
factor’’, was also overrepresented among hypermethylated genes
in astrocytes (P=0.01, Table 1). It is reasonable that develop-
mental genes are shut off by DNA methylation in terminally
differentiated cells. A large part of developmental genes consists of
the transcription factor; therefore, it is also reasonable that a
category related to transcription factor such as ‘‘mRNA transcrip-
tion regulation’’ is overrepresented in hypermethylated genes. It is
interesting to know that the pathway category, ‘‘Notch signaling
pathway’’, is overrepresented 9-fold more than expected among
hypermethylated genes in astrocytes, although it is not statistically
significant (P=0.03). These genes include Dll1, Hes1, Hes5, Hey2,
and Ncor2 (Table 2). The Notch signaling pathway has been shown
to be important in astrocyte differentiation [36]. Inactivation of
developmental and transcriptional factor genes by DNA methyl-
ation is one of the important aspects of differentiation. For
example, inactivation of transcription factor genes, Oct3/4 (Pou5f1)
and Nanog, by DNA methylation is important for early develop-
ment [6,7]. We also found that transcription factor genes were
overrepresented among methylated genes in astrocytes. Regulation
by DNA methylation of transcription factor genes is an attractive
model to explain development and differentiation. Usually
differentiation is caused by transcription factors, which are also
regulated by upstream transcription factors. So what is the most
upstream regulator? One answer is that the most upstream
regulator is epigenetic change.
In conclusion, we suggested in this study that many astrocyte-
specific genes are demethylated in common in late-stage NPCs,
enabling cells to become competent before astrocyte differentia-
tion. This means DNA demethylation rather than methylation is a
critical regulatory event in astrocyte differentiation. We also
indicated that group of genes categorized as developmental and
transcription factor genes are shut off by DNA methylation in
terminally differentiated astrocytes.
Materials and Methods
Methylation profiling by MIAMI
The MIAMI method was performed using one microgram of
genomic DNA as previously described [16,17]. The complete experi-
mental procedure can be obtained at http://grc.dept.med.gunma-u.
ac.jp/,gene/image/MIAMI%20Protocol%20V4.pdf. The micro-
array was the same as that used in our previous paper [17]. A brief
description of the MIAMI method is as follows.
Changes in methylation were judged by using the difference in
methylation-sensitive Hpa II cleavage and methylation-insensitive
Msp I cleavage between samples. To detect differences in
methylation-sensitive Hpa II cleavage, 0.5 microgram of genomic
DNA was digested with 40 units of Hpa II overnight in a 100-
microliter volume containing 33 mM Tris-acetate (pH7.9), 66 mM
KOAc, 10 mM MgOAc2, 0.5 mM DTT, and 0.01% BSA. The
adaptor was prepared by annealing two oligonucleotides, AG-
CACTCTCCAGCCTCTCACCGAG and CGCTCGGTGA. Af-
ter phenol extraction and ethanol precipitation, DNA was ligated to
the adaptor with 60 units of E coli DNA Ligase (Takara, Japan).
The first PCR was performed using 0.1 microgram of each ligation
mix as a template with a primer AGCACTCTCCAGCCTCT-
CACCGAG using GeneTaq DNA polymerase (Nippon Gene,
Japan). The reaction mixture was incubated for 5 min at 72uCa n d
Table 1. Overrepresented category of hypermethylated
genes in astrocytes.
Biological Process Obs/Exp P-value
Mrna transcription regulation 3.7 1.30E-10
Developmental processes 2.8 1.35E-10
Mrna transcription 2.9 4.32E-08
Neurogenesis 3.5 4.67E-04
Endoderm development 3.2 5.93E-04
Nucleoside, nucleotide and nucleic acid metabolism 1.8 3.19E-03
Molecular Function
Obs/
Exp P-value
Transcription factor 2.9 4.29E-09
doi:10.1371/journal.pone.0003189.t001
Table 2. Hypermethylated genes in astrocytes belong to
Notch signaling pathway.
Gene Symbol Gene Name Probe Pos
Dll1 delta-like 1 1725
Hes1 hairy and enhancer of split 1 22503
Hes5 hairy and enhancer of split 5 27260
Hey2
hairy/enhancer-of-split related with YRPW
motif 2
21761
Ncor2 nuclear receptor co-repressor 2 25790
doi:10.1371/journal.pone.0003189.t002
Astrocyte-Specific Genes
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10 sec denaturation at 94uC, 30 sec annealing at 70uC, 2.5 min
extension at 72uC. The final extension was lengthened to 9.5 min.
Amplified DNA was digested with Msp I by adding 35 units of the
enzyme directly to the solution. After 3-hour incubation, the
digested DNA was subjected to further amplification by a second
PCR. The condition was the same as in the first PCR except for the
number of cycles. The optimal sub-saturation cycle number was
adopted (usually 10 to 13 cycles). The PCR product was purified
with a MiniElute PCR purification Kit (Qiagen, USA). To detect of
differences in methylation-insensitive Msp I cleavage, 0.5 micro-
gramofgenomic DNAwas digested with 40unitsofMspI overnight
and subjected to the same procedure as for the amplification of
unmethylated DNA fragments.
Amplified Hpa II-cleaved DNA fragments from two samples to
be compared were labeled with Cy3 and Cy5, respectively, as
described [37], and cohybridized to a microarray. All hybridiza-
tion procedures except for washing were according to the manual
of Agilent Technology (USA). Amplified Msp I-cleaved DNA
fragments from two samples to be compared were labeled with
Cy3 and Cy5, respectively, and cohybridized to another micro-
array with the same probes.
We judged spots with methylation changes using two models;
one in which spots with methylation changes had different values
for Hpa II and Msp I cleavage, and the other in which spots with
methylation changes had a large Hpa II cleavage difference (more
than 5) and a small Msp I cleavage difference (less than 2). The
reproducibility of the experiment was analyzed with 885
triplicated probes on each microarray and repeated experiments.
Bisulfite genomic analysis
Bisulfite treatment of genomic DNA was performed using a
CpGenome DNA modification kit (INTERGEN). Modified DNA
was amplified with the primers described in Table S3. For COBRA
analysis, the restriction enzymes are described in Table S3.
Expression microarray analysis
Expression microarray analysis was performed using the Agilent
mouse whole genome array and the procedure provided by Agilent
Technologies. A signal ratio of more than 2 with a P-value of less
than 0.01 was judged as upregulated. A signal ratio of less than 0.5
with a P-value of less than 0.01 was judged as downregulated.
Animals and cell preparation
Time-pregnant ICR mice were used to prepare NPCs. The
experimental protocols described below were performed according
to the animal experimentation guidelines of Nara Institute of
Science and Technology. NPCs were prepared from telencephalons
of E11.5 and E14.5 mice and cultured as described previously [34].
Briefly, the telencephalons were triturated in Hank’s balanced salt
solution (HBSS) by mild pipetting with a 1-ml pipet tip (Gilson).
Dissociated cells were cultured in N2-supplemented Dulbecco’s
Modified Eagle’s Medium with F12 (GIBCO) containing 10 ng/ml
basic FGF (R&D Systems) (N2/DMEM/F12/bFGF) on culture
dishes (Nunc) of a chamber slide (Nunc) which had been precoated
with poly-L-ornithine (Sigma) and fibronectin (Sigma). For primary
astrocyte cultures, the cerebral cortices of postnatal day 1 mice were
dissociated using trypsin (GIBCO), and cultured for two weeks in
DMEM containing 10% fetal calf serum.
Supporting Information
Table S1 Table S1 Genome-wide profiling of DNA methylation.
Hypomethylated and hypermethylated genes in E14.5 NPCs and
astrocytes compared to E11.5 NPCs. Each row indicates each
probe. Probes with methylation changes are indicated by color as
in Fig. 1A.
Found at: doi:10.1371/journal.pone.0003189.s001 (0.06 MB
XLS)
Table S2 Table S2 List of upregulated genes compared to E11.5
NPCs. Upregulated genes in E14.5 NPCs and astrocytes
compared to E11.5 NPCs.
Found at: doi:10.1371/journal.pone.0003189.s002 (0.55 MB
XLS)
Table S3 Table S3 List of primers and restriction enzymes used
for COBRA and bisulfite sequencing analysis.
Found at: doi:10.1371/journal.pone.0003189.s003 (0.02 MB
XLS)
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